NCT02697929View on ClinicalTrials.gov

Sugammadex/Neostigmine and Liver Transplantation

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Postoperative Residual CurarizationLiver Transplantation
Interventions
DRUG

sugammadex

DRUG

Neostigmine

Trial Locations (1)

33100

AOU Santa Maria della Misericordia, Udine

All Listed Sponsors
lead

Azienda Ospedaliera S. Maria della Misericordia

OTHER

NCT02697929 - Sugammadex/Neostigmine and Liver Transplantation | Biotech Hunter | Biotech Hunter